Clinical Trials Logo

Silent Cerebral Infarction clinical trials

View clinical trials related to Silent Cerebral Infarction.

Filter by:
  • None
  • Page 1

NCT ID: NCT03886675 Recruiting - Stroke Clinical Trials

Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection

INTERCEPT:GP
Start date: November 14, 2022
Phase: N/A
Study type: Interventional

Vascular brain infarction (VBI) occurs in 67% of patients undergoing TEVAR. Overt stroke occurs in 13% of these patients and 88% of patients suffer from neurocognitive impairment. Cerebral air embolisation during the stent-graft deployment phase of TEVAR may be a cause of VBI. Standard treatment to de-air stent-grafts is through the use of a saline flush. This study aims to investigate whether carbon-dioxide or saline is the better fluid to de-air TEVAR stent-grafts prior to insertion in to the patient and compare VBI rate in the carbon-dioxide group and saline group.